logo image
search icon
Periodontal Therapeutics Market

Periodontal Therapeutics Market Size, Share & Trends Analysis Report, By Disease (Chronic Periodontal Disease, Aggressive Periodontal Disease, Gingivitis), By Drug Type (Doxycycline, Minocycline, Chlorhexidine, Metronidazole)), By Distribution Channel, By Region, Forecasts, 2024-2031

Report ID : 2576 | Published : 2024-07-17 | Pages: 175 | Format: PDF/EXCEL

The Periodontal Therapeutics Market Size was valued at USD 843.6 Mn in 2023 and is predicted to reach USD 1,497.4 Mn by 2031 at a 7.6% CAGR during the forecast period for 2024-2031.

periodontal

Periodontal disease encompasses a wide range of inflammatory conditions affecting the tissues surrounding the teeth. It primarily includes gingivitis (mild inflammation of the gums) and periodontitis (severe inflammation that can lead to tooth loss). Gingivitis is reversible with the help of proper care, but if it is left untreated, it can lead to periodontitis, which is more challenging to manage. The growth of the market is due to the growing prevalence of periodontal diseases. Increasing awareness about oral health, the rising geriatric population, and technological advancements in dentistry are further propelling the growth of the market. Also, the recommendation of drugs like antibiotics is rising in the same field. It is quite advantageous for the growth of the periodontal market.

The COVID-19 pandemic has significantly impacted the periodontal therapeutics market. Dental clinics and periodontal practices faced temporary closures and reduced patient visits due to lockdowns and social distancing measures. It led to a decline in the demand for periodontal treatments. However, the pandemic also heightened awareness of the importance of oral health, potentially driving future market growth. Telehealth services and remote consultations emerged as alternative approaches, aiding in patient management during the crisis. As restrictions ease and normalcy returns, the market is expected to recover, with an increased focus on infection control and preventive care.

Competitive Landscape

Some of the Major Key Players in the Periodontal Therapeutics Market are

  • Pfizer Inc.
  • Lupin Ltd
  • Teva Pharmaceuticals USA, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Tokyo Chemical Industry Co., Ltd.
  • Bausch Health Companies Inc.
  • USAntibiotics
  • Melinta Therapeutics LLC
  • Cipla, Inc.
  • Chartwell Pharmaceuticals LLC.
  • Other Prominent Players

Market Segmentation:

The periodontal therapeutics market is segmented on the basis of disease, drug type, and distributional channel. By Disease type, the market segments include gingivitis, chronic periodontal disease, aggressive periodontal disease, and others. On the basis of drug type, the segments are doxycycline, minocycline, chlorhexidine, metronidazole, and others. By distribution channel, the segmentation includes hospital pharmacies, retail pharmacies, and online channels.

Based on Disease Type, the Gingivitis Segment is Considered a Major Contributor to the Periodontal Therapeutics Market.  

The gingivitis segment of the periodontal therapeutics market is growing due to increased awareness of oral health and the prevalence of gum diseases. Gingivitis, an early stage of periodontal disease, is the inflammation of the gums as well as can lead to many severe conditions if untreated. The market includes various treatment options, such as antiseptic mouthwashes, antibiotics, and professional dental cleanings. Innovations in dental care products and a rising focus on preventive healthcare are driving market growth. Additionally, increased dental visits and advancements in diagnostic tools contribute to the expansion of this segment within the periodontal therapeutics market.

The Doxycycline Segment Witnessed Growth at a Rapid Rate.

The doxycycline segment of the periodontal therapeutics market is a significant component in treating periodontal diseases. Doxycycline, a type of antibiotic, is commonly used in the form of gel or subgingival fibers to target specific bacteria causing periodontitis. It works by reducing inflammation and inhibiting bacterial growth in the periodontal pockets. The segment is seen to grow due to the effectiveness of doxycycline in managing periodontal conditions, its ease of application, and favorable patient outcomes. With increasing emphasis on oral health and advancements in periodontal treatments, the doxycycline segment plays a crucial role in the periodontal therapeutics market.

In the Region, the North American Periodontal Therapeutics Market Holds a Significant Revenue Share.

North America's periodontal therapeutics market dominates the market. It has been initiated to increase awareness about oral health—the rise in effective procedures for the treatment and diagnosis of periodontal diseases. Hence, the sales of periodontal treatment products, including both drugs and devices, in the region are quite high. Asia Pacific is to be seen to grow at a rapid rate in the global periodontal therapeutics market due to growing concerns about rapid industrialization, government initiatives, and increasing funding in various industries.

Recent Developments:

  • In February 2020, AMD Lasers announced the development of the Monet™ laser curing light, the first handheld laser in curing light for dental materials.
  • In 2019, OraVu, which is a dental technology company dealing in dental endoscopy solutions, launched a complete micro-endoscope system called DeVA-1® Dental Vision Assistant.

 

Periodontal Therapeutics Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 843.6 Mn

Revenue Forecast In 2031

USD 1,497.4 Mn

Growth Rate CAGR

CAGR of 7.6% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Disease, By Drug Type, By Distribution Channel and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

Pfizer Inc., Lupin Ltd., Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries Ltd., Tokyo Chemical Industry Co., Ltd., Bausch Health Companies Inc., USAntibiotics, Melinta Therapeutics LLC, Cipla, Inc., Chartwell Pharmaceuticals LLC, and other prominent players.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Periodontal Therapeutics Market Snapshot

Chapter 4. Global Periodontal Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: Disease Outlook Estimates & Trend Analysis
5.1. Disease Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Outlook:

5.2.1. Gingivitis
5.2.2. Chronic Periodontal Disease
5.2.3. Aggressive Periodontal Disease
5.2.4. Others

Chapter 6. Market Segmentation 2: Drug Type Outlook Estimates & Trend Analysis
6.1. Drug Type Outlook & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Drug Type Outlook:

6.2.1. Doxycycline
6.2.2. Minocycline
6.2.3. Chlorhexidine
6.2.4. Metronidazole
6.2.5. Other drug types

Chapter 7. Market Segmentation 3: Distribution Channel Outlook Estimates & Trend Analysis
7.1. Distribution Channel Outlook & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channel Outlook:

7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Channel

Chapter 8. Periodontal Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America
8.1.1. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.1.2. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.1.3. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.1.4. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031


8.2. Europe
8.2.1. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.2.2. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.2.3. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.2.4. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031


8.3. Asia Pacific
8.3.1. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.3.2. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.3.3. Asia-Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.3.4. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031


8.4. Latin America
8.4.1. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.4.2. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.4.3. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.4.4. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031


8.5. Middle East & Africa
8.5.1. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.5.2. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.5.3. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.5.4. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031


Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. Pfizer Inc.
9.2.2. Lupin Ltd
9.2.3. Teva Pharmaceuticals USA, Inc.
9.2.4. Sun Pharmaceutical Industries Ltd.
9.2.5. Tokyo Chemical Industry Co., Ltd.
9.2.6. Bausch Health Companies Inc.
9.2.7. USAntibiotics
9.2.8. Melinta Therapeutics LLC
9.2.9. Cipla, Inc.
9.2.10. Chartwell Pharmaceuticals LLC.

 

Segmentation of the Periodontal Therapeutics Market

Periodontal Therapeutics Market - By Disease

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Others

periodontal

Periodontal Therapeutics Market - By Drug Type

  • Doxycycline
  • Minocycline
  • Chlorhexidine
  • Metronidazole
  • Other drug types

Periodontal Therapeutics Market - By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channel

 Periodontal Therapeutics Market - By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Periodontal Therapeutics Market size?

The Periodontal Therapeutics Market is expected to grow at a 7.6% CAGR during the forecast period for 2024-2031.

Pfizer Inc., Lupin Ltd., Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries Ltd., Tokyo Chemical Industry Co., Ltd., Bausch Health Companie

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach